SNOA logo

Sonoma Pharmaceuticals (SNOA) Net Income

Annual Net Income

-$4.83 M
+$316.00 K+6.13%

March 31, 2024


Summary


Performance

SNOA Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSNOAprofitabilitymetrics:

Quarterly Net Income

-$928.00 K
-$318.00 K-52.13%

December 31, 2024


Summary


Performance

SNOA Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSNOAprofitabilitymetrics:

TTM Net Income

-$3.75 M
-$62.00 K-1.68%

December 31, 2024


Summary


Performance

SNOA TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSNOAprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

SNOA Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+6.1%-7.2%+26.2%
3 y3 years-22.4%+29.1%+27.2%
5 y5 years+59.0%+29.1%+27.2%

SNOA Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-22.4%+6.1%-52.1%+68.5%-1.7%+44.8%
5 y5-year-46.2%+59.0%-486.7%+74.6%-85.0%+44.8%
alltimeall time-152.1%+79.1%-105.7%+86.6%-140.4%+83.8%

Sonoma Pharmaceuticals Net Income History

DateAnnualQuarterlyTTM
Dec 2024
-
-$928.00 K(+52.1%)
-$3.75 M(+1.7%)
Sep 2024
-
-$610.00 K(-46.6%)
-$3.69 M(-19.2%)
Jun 2024
-
-$1.14 M(+7.1%)
-$4.56 M(-5.7%)
Mar 2024
-$4.83 M(-6.1%)
-$1.07 M(+23.2%)
-$4.83 M(-4.7%)
Dec 2023
-
-$866.00 K(-41.6%)
-$5.08 M(-17.4%)
Sep 2023
-
-$1.48 M(+4.7%)
-$6.15 M(+8.2%)
Jun 2023
-
-$1.42 M(+8.4%)
-$5.68 M(+10.3%)
Mar 2023
-$5.15 M(+1.3%)
-$1.31 M(-32.5%)
-$5.15 M(-24.1%)
Dec 2022
-
-$1.94 M(+90.7%)
-$6.79 M(+17.2%)
Sep 2022
-
-$1.02 M(+14.7%)
-$5.79 M(+18.8%)
Jun 2022
-
-$887.00 K(-69.9%)
-$4.88 M(-4.1%)
Mar 2022
-$5.09 M(+28.8%)
-$2.94 M(+211.9%)
-$5.09 M(-12.3%)
Dec 2021
-
-$944.00 K(+844.0%)
-$5.80 M(+5.3%)
Sep 2021
-
-$100.00 K(-90.9%)
-$5.51 M(+4.2%)
Jun 2021
-
-$1.10 M(-70.0%)
-$5.29 M(+33.9%)
Mar 2021
-$3.95 M(+19.4%)
-$3.66 M(+463.1%)
-$3.95 M(+95.0%)
Dec 2020
-
-$650.00 K(-641.7%)
-$2.03 M(-17.6%)
Sep 2020
-
$120.00 K(-50.0%)
-$2.46 M(-35.0%)
Jun 2020
-
$240.00 K(-113.8%)
-$3.78 M(+14.4%)
Mar 2020
-$3.31 M(-72.0%)
-$1.74 M(+60.1%)
-$3.31 M(-31.0%)
Dec 2019
-
-$1.08 M(-9.9%)
-$4.79 M(-20.2%)
Sep 2019
-
-$1.20 M(-268.3%)
-$6.01 M(-21.2%)
Jun 2019
-
$715.00 K(-122.2%)
-$7.63 M(-35.4%)
Mar 2019
-$11.80 M(-17.7%)
-$3.22 M(+40.2%)
-$11.80 M(-11.6%)
Dec 2018
-
-$2.30 M(-18.5%)
-$13.34 M(-6.2%)
Sep 2018
-
-$2.82 M(-18.4%)
-$14.23 M(-0.4%)
Jun 2018
-
-$3.46 M(-27.4%)
-$14.28 M(-0.3%)
Mar 2018
-$14.33 M(-254.5%)
-$4.76 M(+49.5%)
-$14.33 M(+19.4%)
Dec 2017
-
-$3.19 M(+11.0%)
-$12.00 M(-261.9%)
Sep 2017
-
-$2.87 M(-18.2%)
$7.41 M(-11.0%)
Jun 2017
-
-$3.51 M(+44.0%)
$8.34 M(-10.1%)
Mar 2017
$9.27 M(-191.3%)
-$2.44 M(-115.0%)
$9.28 M(+5.4%)
Dec 2016
-
$16.23 M(-932.6%)
$8.80 M(-183.2%)
Sep 2016
-
-$1.95 M(-24.1%)
-$10.58 M(+1.8%)
Jun 2016
-
-$2.57 M(-11.8%)
-$10.39 M(+2.2%)
Mar 2016
-$10.16 M(+23.9%)
-$2.91 M(-7.6%)
-$10.16 M(+16.1%)
Dec 2015
-
-$3.15 M(+78.6%)
-$8.75 M(-24.0%)
Sep 2015
-
-$1.76 M(-24.7%)
-$11.52 M(+10.0%)
Jun 2015
-
-$2.34 M(+55.9%)
-$10.47 M(+27.7%)
Mar 2015
-$8.20 M(-319.6%)
-$1.50 M(-74.6%)
-$8.20 M(-1186.5%)
Dec 2014
-
-$5.91 M(+723.7%)
$755.00 K(-87.5%)
Sep 2014
-
-$718.00 K(+925.7%)
$6.06 M(+12.7%)
Jun 2014
-
-$70.00 K(-100.9%)
$5.38 M(+44.0%)
DateAnnualQuarterlyTTM
Mar 2014
$3.73 M(-168.8%)
$7.46 M(-1320.5%)
$3.73 M(-160.6%)
Dec 2013
-
-$611.00 K(-56.3%)
-$6.17 M(-17.4%)
Sep 2013
-
-$1.40 M(-18.3%)
-$7.47 M(-1.6%)
Jun 2013
-
-$1.71 M(-30.0%)
-$7.59 M(+39.7%)
Mar 2013
-$5.43 M(-25.9%)
-$2.44 M(+27.9%)
-$5.43 M(+14.2%)
Dec 2012
-
-$1.91 M(+25.9%)
-$4.75 M(-11.8%)
Sep 2012
-
-$1.52 M(-441.3%)
-$5.39 M(+14.4%)
Jun 2012
-
$445.00 K(-125.2%)
-$4.71 M(-35.7%)
Mar 2012
-$7.33 M(-7.8%)
-$1.77 M(-30.6%)
-$7.33 M(+1.0%)
Dec 2011
-
-$2.55 M(+203.6%)
-$7.25 M(+4.6%)
Sep 2011
-
-$839.00 K(-61.4%)
-$6.94 M(-10.5%)
Jun 2011
-
-$2.17 M(+28.4%)
-$7.75 M(-2.5%)
Mar 2011
-$7.95 M(-3.4%)
-$1.69 M(-24.0%)
-$7.95 M(+3.1%)
Dec 2010
-
-$2.23 M(+35.2%)
-$7.71 M(+13.0%)
Sep 2010
-
-$1.65 M(-30.6%)
-$6.82 M(-3.5%)
Jun 2010
-
-$2.38 M(+63.6%)
-$7.07 M(-14.2%)
Mar 2010
-$8.23 M(-53.4%)
-$1.45 M(+7.9%)
-$8.23 M(-8.6%)
Dec 2009
-
-$1.35 M(-28.9%)
-$9.01 M(-18.0%)
Sep 2009
-
-$1.89 M(-46.5%)
-$10.98 M(-31.4%)
Jun 2009
-
-$3.54 M(+59.1%)
-$16.00 M(-9.4%)
Mar 2009
-$17.66 M(-13.2%)
-$2.23 M(-33.0%)
-$17.66 M(-11.3%)
Dec 2008
-
-$3.32 M(-52.0%)
-$19.91 M(-9.1%)
Sep 2008
-
-$6.91 M(+32.9%)
-$21.89 M(+6.7%)
Jun 2008
-
-$5.20 M(+16.2%)
-$20.52 M(+0.9%)
Mar 2008
-$20.34 M(+2.8%)
-$4.47 M(-15.6%)
-$20.34 M(-8.2%)
Dec 2007
-
-$5.30 M(-4.3%)
-$22.16 M(+2.2%)
Sep 2007
-
-$5.54 M(+10.4%)
-$21.68 M(+5.7%)
Jun 2007
-
-$5.02 M(-20.2%)
-$20.50 M(+3.5%)
Mar 2007
-$19.78 M(-14.4%)
-$6.29 M(+30.3%)
-$19.82 M(-1.9%)
Dec 2006
-
-$4.83 M(+10.5%)
-$20.21 M(-8.4%)
Sep 2006
-
-$4.37 M(+0.8%)
-$22.06 M(-2.2%)
Jun 2006
-
-$4.33 M(-35.1%)
-$22.56 M(-2.3%)
Mar 2006
-$23.10 M(+39.7%)
-$6.68 M(-0.0%)
-$23.10 M(+12.4%)
Dec 2005
-
-$6.68 M(+37.1%)
-$20.55 M(+14.1%)
Sep 2005
-
-$4.87 M(0.0%)
-$18.01 M(+4.3%)
Jun 2005
-
-$4.87 M(+17.9%)
-$17.27 M(+4.5%)
Mar 2005
-$16.53 M(+126.5%)
-$4.13 M(-0.0%)
-$16.53 M(+33.3%)
Dec 2004
-
-$4.13 M(0.0%)
-$12.40 M(+50.0%)
Sep 2004
-
-$4.13 M(0.0%)
-$8.27 M(+100.0%)
Jun 2004
-
-$4.13 M
-$4.13 M
Mar 2004
-$7.30 M(+357.6%)
-
-
Mar 2003
-$1.59 M(+855.1%)
-
-
Mar 2002
-$167.00 K
-
-

FAQ

  • What is Sonoma Pharmaceuticals annual net profit?
  • What is the all time high annual net income for Sonoma Pharmaceuticals?
  • What is Sonoma Pharmaceuticals annual net income year-on-year change?
  • What is Sonoma Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for Sonoma Pharmaceuticals?
  • What is Sonoma Pharmaceuticals quarterly net income year-on-year change?
  • What is Sonoma Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for Sonoma Pharmaceuticals?
  • What is Sonoma Pharmaceuticals TTM net income year-on-year change?

What is Sonoma Pharmaceuticals annual net profit?

The current annual net income of SNOA is -$4.83 M

What is the all time high annual net income for Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals all-time high annual net profit is $9.27 M

What is Sonoma Pharmaceuticals annual net income year-on-year change?

Over the past year, SNOA annual net profit has changed by +$316.00 K (+6.13%)

What is Sonoma Pharmaceuticals quarterly net profit?

The current quarterly net income of SNOA is -$928.00 K

What is the all time high quarterly net income for Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals all-time high quarterly net profit is $16.23 M

What is Sonoma Pharmaceuticals quarterly net income year-on-year change?

Over the past year, SNOA quarterly net profit has changed by -$62.00 K (-7.16%)

What is Sonoma Pharmaceuticals TTM net profit?

The current TTM net income of SNOA is -$3.75 M

What is the all time high TTM net income for Sonoma Pharmaceuticals?

Sonoma Pharmaceuticals all-time high TTM net profit is $9.28 M

What is Sonoma Pharmaceuticals TTM net income year-on-year change?

Over the past year, SNOA TTM net profit has changed by +$1.33 M (+26.16%)